Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Factors Affecting Illness01:18

Factors Affecting Illness

4.3K
When a person's physical, emotional, intellectual, social development or spiritual functioning is compromised, this deviation from a healthy normal state is called illness. Illness creates stress that in turn harms individuals. Irritation, anger, denial, hopelessness, and fear are behavioral and emotional changes an individual experiences in the phases of illness. A variety of factors influence a person's health and well-being.
For instance, risk factors are connected to illness,...
4.3K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

407
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
407
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

2.9K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.9K
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

12.1K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
12.1K
Causality in Epidemiology01:21

Causality in Epidemiology

584
Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...
584
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

2.9K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Alpha2 agonists for sedation to produce better outcomes for adults with critical illness: a synopsis of the A2B RCT with cost-effectiveness and process evaluation.

Health technology assessment (Winchester, England)·2026
Same author

Rationalising heterogeneity in Staphylococcus aureus bacteraemia: current progress and future goals.

The Journal of infectious diseases·2026
Same author

Disease-associated genetic variants can cause missense effects in tissue-specific protein isoforms.

Nature communications·2026
Same author

Temporal trends in time to asystole in patients considered for organ donation after circulatory death.

Journal of the Intensive Care Society·2026
Same author

Respiratory Virus Coinfection Is a Risk Factor for Adverse Outcomes During <i>Staphylococcus aureus</i> Bacteremia.

Open forum infectious diseases·2026
Same author

Early risk stratification in Staphylococcus aureus bacteraemia: External validation of the FEN-AUREUS classification in a UK cohort.

International journal of antimicrobial agents·2026

Related Experiment Video

Updated: Aug 9, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.3K

Comorbidities, multimorbidity and COVID-19.

Clark D Russell1, Nazir I Lone2,3, J Kenneth Baillie4,5,6

  • 1Centre for Inflammation Research, The Queen's Medical Research Institute, University of Edinburgh, Edinburgh BioQuarter, Edinburgh, UK.

Nature Medicine
|February 16, 2023
PubMed
Summary
This summary is machine-generated.

Comorbidities significantly impact COVID-19 outcomes by worsening disease progression through distinct pathological mechanisms. Host genetics may offer causal insights, aiding targeted therapies for better patient results.

More Related Videos

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
08:48

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Published on: February 16, 2022

3.0K
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

2.8K

Related Experiment Videos

Last Updated: Aug 9, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.3K
Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
08:48

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Published on: February 16, 2022

3.0K
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

2.8K

Area of Science:

  • Infectious Diseases
  • Immunology
  • Genetics

Background:

  • Comorbidities have long been linked to severe COVID-19 outcomes.
  • Establishing causal links and mechanisms is complex due to confounding factors and patient variability.
  • COVID-19 progresses through distinct phases, each with unique pathological mechanisms influenced by comorbidities.

Purpose of the Study:

  • To review the impact of comorbidities and multimorbidity on the three distinct phases of COVID-19.
  • To explore the role of host genetics in understanding causal inference for COVID-19 outcomes.
  • To discuss clinical implications for therapeutic strategies.

Main Methods:

  • Literature review focusing on comorbidities, multimorbidity, and COVID-19 pathogenesis.
  • Analysis of pathological mechanisms across COVID-19 phases.
  • Discussion of host genetics as a tool for causal inference.

Main Results:

  • Specific comorbidities can exacerbate COVID-19 pathological mechanisms or reduce organ injury tolerance.
  • Multimorbidity presents a complex challenge in predicting COVID-19 severity.
  • Host genetics offers a potential method to mitigate confounding factors in outcome research.

Conclusions:

  • Understanding disease-state interactions is critical for stratifying treatments.
  • Host genetics can elucidate causal relationships between comorbidities and COVID-19.
  • Further research is needed to refine therapeutic approaches and improve patient outcomes in COVID-19.